Faruqi & Faruqi Replaces Pomerantz In Allergan Suit
Faruqi & Faruqi will represent a proposed class of investors in the pharmaceutical company Allergan after Pomerantz lost its lead counsel status in the consolidated securities litigation, a Manhattan federal judge...To view the full article, register now.
Already a subscriber? Click here to view full article